| Serum lipid levels and suicidality among male patients with schizoaffective disorder. | |
| | |
MedLine Citation:
|
PMID: 17850945 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Suicidal behavior in schizoaffective disorder is a serious problem and suicide risk during lifetime ranges between 5%-10%. Neurobiology of suicidal behavior has not been studied sufficiently, and a high number of studies are oriented toward lipid investigation. The aim of our study was to investigate whether there were differences in the level of lipids (cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides) in hospitalized suicidal (n=20) and non-suicidal (n=20) patients with schizoaffective disorder. The study also included male healthy control subjects (n=20). Hamilton Depression Rating Scale (HDRS-17), and Positive and Negative Syndrome Scale (PANSS) were used to confirm the level of psychopathology in patients with schizoaffective disorder. Severity of suicidality was measured by Scale for Suicide Ideation (SSI) at time of admission. Results of the study indicated significantly lower concentrations of cholesterol (p<0.001), LDL-cholesterol (p<0.01) and HDL-cholesterol (p<0.01). There were no differences in the number of previous hospitalization and previous suicide attempts between suicidal and non-suicidal patients (p>0.05). Duration of the illness was significantly (p<0.05) shorter in suicidal patients. Suicidal patients also had a significantly higher score on HDRS-17 (p<0.001) and PANSS (p<0.01) compared to non-suicidal patients. |
| | |
Authors:
|
Darko Marcinko; Vesna Marcinko; Dalibor Karlović; Anita Marcinko; Marko Martinac; Drazen Begić; Miro Jakovljević |
Related Documents
:
|
22594305 - Esophageal motor dysfunction plays a key role in gerd with globus sensation--analysis o... 22129515 - The balance of fetuin-a and osteoprotegerin is independently associated with diastolic ... 21719525 - Role of fibrinolytic parameters and plasminogen activator inhibitor 1 (pai-1) promoter ... 7946245 - Effects of three treatment modes on plasma lipids and lipoproteins in uraemic patients. 21497795 - The association of elevated body mass index with reduced brain volumes in first-episode... 22594305 - Esophageal motor dysfunction plays a key role in gerd with globus sensation--analysis o... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2007-08-19 |
Journal Detail:
|
Title: Progress in neuro-psychopharmacology & biological psychiatry Volume: 32 ISSN: 0278-5846 ISO Abbreviation: Prog. Neuropsychopharmacol. Biol. Psychiatry Publication Date: 2008 Jan |
Date Detail:
|
Created Date: 2008-01-24 Completed Date: 2008-05-02 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8211617 Medline TA: Prog Neuropsychopharmacol Biol Psychiatry Country: England |
Other Details:
|
Languages: eng Pagination: 193-6 Citation Subset: IM |
Affiliation:
|
Department of Psychiatry, University Hospital Zagreb, Kispatićeva 12, 10000 Zagreb, Croatia. darko.marcinko@zg.t-com.hr |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Humans Lipids / blood* Male Middle Aged Psychiatric Status Rating Scales Psychotic Disorders / blood*, psychology* Suicide* |
| Chemical | |
Reg. No./Substance:
|
0/Lipids |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Do diseases have a prestige hierarchy? A survey among physicians and medical students.
Next Document: A case-control association study of the polymorphism at the promoter region of the DRD4 gene in Kore...